Legal Representation
Attorney
H. MATHEWS GARLAND
USPTO Deadlines
Application History
16 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 3, 1999 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Dec 16, 1998 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Nov 20, 1998 | EXT3 | S | SOU EXTENSION 3 FILED |
| Jun 15, 1998 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jun 2, 1998 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jan 29, 1998 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jan 14, 1998 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jul 15, 1997 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 22, 1997 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 21, 1997 | NPUB | O | NOTICE OF PUBLICATION |
| Feb 20, 1997 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 16, 1996 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 25, 1996 | CNFR | O | FINAL REFUSAL MAILED |
| Feb 15, 1996 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Aug 21, 1995 | CNRT | F | NON-FINAL ACTION MAILED |
| Aug 18, 1995 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 005
microspheres, namely, pharmaceutical capsules, sold empty; microspheres, namely, pharmaceutical capsules containing diagnostic reagents, and drugs for the treatment of heart disease, antibiotics, anti-inflammatories, and anti-cancer drugs
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
design and manufacture to the order and specification of others of microsphers, namely, pharmaceutical capsules, and pharmaceutical drugs and diagnostic reagents contained in microspheres
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042